Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 23, 2013, Pages 9457-9462

  Yaesoubi, Reza ^a,b,c   Cohen, Ted ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Approximate dynamic programming; Cost effectiveness; Dynamic resource allocation; Mathematical model; Screening

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DISEASE TRANSMISSION; EPIDEMIC; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TUBERCULOSIS;

APPROXIMATE DYNAMIC PROGRAMMING; COST-EFFECTIVENESS; DYNAMIC RESOURCE ALLOCATION; MATHEMATICAL MODEL; SCREENING;

DECISION SUPPORT TECHNIQUES; EPIDEMICS; EPIDEMIOLOGICAL MONITORING; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; PREVALENCE; PUBLIC HEALTH; PUBLIC POLICY; TUBERCULOSIS;

EID: 84878682928     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1218770110     Document Type: Article

References (47)

1. World Health Organization (2012) Global Tuberculosis Report. www.who.int/tb/publications/global-report/en/. Accessed April 28, 2013.
2. Banerji D, Andersen S (1963) A sociological study of awareness of symptoms among persons with pulmonary tuberculosis. Bull World Health Organ 29(5):665-683.
3. Nagpaul DR, Vishwanath MK, Dwarakanath G (1970) A socio-epidemiological study of out-patients attending a city tuberculosis clinic in India to judge the place of specialized centres in a tuberculosis control programme. Bull World Health Organ 43(1): 17-34.
4. Murray CJL, et al. (1991) Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 338(8778):1305-1308.
5. Suárez PG, et al. (2001) The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis 184(4):473-478.
6. Dye C, Fengzeng Z, Scheele S, Williams B (2000) Evaluating the impact of tuberculosis control: Number of deaths prevented by short-course chemotherapy in China. Int J Epidemiol 29(3):558-564.
7. De Cock KM, Chaisson RE (1999) Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 3(6):457-465.
8. Godfrey-Faussett P (2011) Do we need to go beyond the clinic to control TB? 42nd Union World Conference on Lung Health, Lille, France. Available at http://uwclh. conference2web.com/content/1060.
9. H. Ayles and the ZAMSTAR Study Team (2011) A household-based HIV and TB intervention increases HIV testing in households and reduces prevalence of TB at the community level: The ZAMSTAR community randomized trial. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA. Available at www.retroconference.org/2012b/Abstracts/45440.htm.
10. Murray CJL, Salomon JA (1998) Expanding the WHO tuberculosis control strategy: Rethinking the role of active case-finding. Int J Tuberc Lung Dis 2(9, Suppl 1)S9-S15.
11. Murray CJL, Salomon JA (1998) Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA 95(23):13881-13886.
12. Dowdy DW, Chaisson RE (2009) The persistence of tuberculosis in the age of DOTS: Reassessing the effect of case detection. Bull World Health Organ 87(4):296-304.
13. Currie CSM, Floyd K, Williams BG, Dye C (2005) Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. BMC Public Health 5:130.
14. Lönnroth K, et al. (2013) Systematic screening for active tuberculosis: Rationale, definitions and key considerations. Int J Tuberc Lung Dis 17(3):289-298.
15. BorgdorffMW, Yew WW, Marks G (2013) Active tuberculosis case finding: Why, when and how? Int J Tuberc Lung Dis 17(3):285.
16. Dodd PJ, White RG, Corbett EL (2011) Periodic active case finding for TB: When to look? PLoS ONE 6(12):e29130.
17. Churchyard GJ, et al. (2011) Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trial. Thorax 66(2): 134-139.
18. Martin L (1994) Puterman. Markov Decision Processes: Discrete Stochastic Dynamic Programming (Wiley, New York).
19. White CC, Scherer WT (1994) Finite-memory suboptimal design for partially observed Markov decision processes. Oper Res 42(3):439-455.
20. Abu-Raddad LJ, et al. (2009) Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci USA 106(33):13980-13985.
21. Currie CSM, Williams BG, Cheng RCH, Dye C (2003) Tuberculosis epidemics driven by HIV: Is prevention better than cure? AIDS 17(17):2501-2508.
22. Dowdy DW, Chaisson RE, Moulton LH, Dorman SE (2006) The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: A mathematical model. AIDS 20(5):751-762.
23. Daley CL, et al. (1992) An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 326(4):231-235.
24. Shafer RW, Singh SP, Larkin C, Small PM (1995) Exogenous reinfection with multidrugresistant Mycobacterium tuberculosis in an immunocompetent patient. Tuber Lung Dis 76(6):575-577.
25. Bucher HC, et al. (1999) Isoniazid prophylaxis for tuberculosis in HIV infection: A meta-analysis of randomized controlled trials. AIDS 13(4):501-507.
26. Corbett EL, et al. (2003) The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 163(9):1009-1021.
27. Elliott AM, et al. (1993) The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. J Trop Med Hyg 96(1):1-11.
28. Getahun H, Harrington M, O'Brien R, Nunn P (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: Informing urgent policy changes. Lancet 369(9578):2042-2049.
29. Manosuthi W, et al. (2010) Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: A four-year prospective study. Int J Infect Dis 14(11):e1013-e1017.
30. van der Sande MAB, et al. (2004) Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS 18(14):1933-1941.
31. Barry CE, 3rd, et al. (2009) The spectrum of latent tuberculosis: Rethinking the biology and intervention strategies. Nat Rev Microbiol 7(12):845-855.
32. Mack U, et al.; C. Lange; TBNET (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33(5):956-973.
33. Corbett EL, et al. (2007) Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 4(1):e22.
34. Wood R, et al. (2007) Undiagnosed tuberculosis in a community with high HIV prevalence: Implications for tuberculosis control. Am J Respir Crit Care Med 175(1): 87-93.
35. Boehme CC, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363(11):1005-1015.
36. Boehme CC, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet 377(9776):1495-1505.
37. Theron G, et al. (2011) Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 184(1):132-140.
38. Corbett EL, et al. (2010) Comparison of two active case-finding strategies for community- based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): A cluster-randomised trial. Lancet 376(9748):1244-1253.
39. Yaesoubi R, Cohen T (2011) Generalized Markov models of infectious disease spread: A novel framework for developing dynamic health policies. Eur J Oper Res 215(3): 679-687.
40. UNAIDS AIDSInfo. www.unaids.org/en/dataanalysis/datatools/aidsinfo/ Accessed April 28, 2013.
41. Andrew Briggs (2006) Karl Claxton, and Mark Sculpher. Decision Modelling for Health Economic Evaluation (Oxford Univ Press, Oxford).
42. Ahmad RA, Mahendradhata Y, Cunningham J, Utarini A, de Vlas SJ (2009) How to optimize tuberculosis case finding: Explorations for Indonesia with a health system model. BMC Infect Dis 9(1):87.
43. Becerra MC, et al. (2005) Expanding tuberculosis case detection by screening household contacts. Public Health Rep 120(3):271-277.
44. Kranzer K, et al. (2010) Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: A systematic review and meta-analysis. Lancet Infect Dis 10(2):93-102.
45. Miller AC, et al. (2010) Controlled trial of active tuberculosis case finding in a Brazilian favela. Int J Tuberc Lung Dis 14(6):720-726.
46. den Boon S, et al. (2008) Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: The additional value of active case finding. Epidemiol Infect 136(10):1342-1349.
47. Ward HA, Marciniuk DD, Pahwa P, Hoeppner VH (2004) Extent of pulmonary tuberculosis in patients diagnosed by active compared to passive case finding. Int J Tuberc Lung Dis 8(5):593-597.